SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy.

Cauley, ES; Pittman, A; Mummidivarpu, S; Karimiani, EG; Martinez, S; Moroni, I; Boostani, R; Podini, D; Mora, M; Jamshidi, Y; et al. Cauley, ES; Pittman, A; Mummidivarpu, S; Karimiani, EG; Martinez, S; Moroni, I; Boostani, R; Podini, D; Mora, M; Jamshidi, Y; Hoffman, EP; Manzini, MC (2020) Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy. Mol Genet Genomic Med, 8 (11). e1387. ISSN 2324-9269 https://doi.org/10.1002/mgg3.1387
SGUL Authors: Jamshidi, Yalda

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (670kB) | Preview

Abstract

BACKGROUND: Congenital muscular dystrophy type 1A (MDC1A), also termed merosin-deficient congenital muscular dystrophy (CMD), is a severe form of CMD caused by mutations in the laminin α2 gene (LAMA2). Of the more than 300 likely pathogenic variants found in the Leiden Open Variant Database, the majority are truncating mutations leading to complete LAMA2 loss of function, but multiple copy number variants (CNVs) have also been reported with variable frequency. METHODS: We collected a cohort of individuals diagnosed with likely MDC1A and sought to identify both single nucleotide variants and small and larger CNVs via exome sequencing by extending the analysis of sequencing data to detect splicing changes and CNVs. RESULTS: Standard exome analysis identified multiple novel LAMA2 variants in our cohort, but only four cases carried biallelic variants. Since likely truncating LAMA2 variants are often found in heterozygosity without a second allele, we performed additional splicing and CNV analysis on exome data and identified one splice change outside of the canonical sequences and three CNVs, in the remaining four cases. CONCLUSIONS: Our findings support the expectation that a portion of MDC1A cases may be caused by at least one CNV allele and show how these changes can be effectively identified by additional analysis of existing exome data.

Item Type: Article
Additional Information: © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Keywords: LAMA2, CNV analysis, congenital muscular dystrophy, exome sequencing
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Mol Genet Genomic Med
ISSN: 2324-9269
Language: eng
Dates:
DateEvent
15 November 2020Published
16 September 2020Published Online
21 May 2020Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
293587Muscular Dystrophy AssociationUNSPECIFIED
6-FY14 422March of Dimes FoundationUNSPECIFIED
R01NS109149NINDS NIH HHSUNSPECIFIED
PubMed ID: 32936536
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112420
Publisher's version: https://doi.org/10.1002/mgg3.1387

Actions (login required)

Edit Item Edit Item